CRL
Charles River Laboratories International Inc
Price:  
254.19 
USD
Volume:  
641,893.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRL EV/EBITDA

11.2%
Upside

As of 2024-03-01, the EV/EBITDA ratio of Charles River Laboratories International Inc (CRL) is 16.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRL's latest enterprise value is 15,415.90 mil USD. CRL's TTM EBITDA according to its financial statements is 939.40 mil USD. Dividing these 2 quantities gives us the above CRL EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 14.4x - 16.8x 16.2x
Forward P/E multiples 14.5x - 18.4x 16.2x
Fair Price 217.74 - 366.52 282.73
Upside -14.3% - 44.2% 11.2%
254.19 USD
Stock Price
282.73 USD
Fair Price

CRL EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-29 16.41
2024-02-28 16.55
2024-02-27 16.34
2024-02-26 16.16
2024-02-23 16.06
2024-02-22 16.01
2024-02-21 15.70
2024-02-20 15.58
2024-02-16 15.91
2024-02-15 15.93
2024-02-14 15.92
2024-02-13 14.56
2024-02-12 14.86
2024-02-09 14.66
2024-02-08 14.48
2024-02-07 14.47
2024-02-06 14.57
2024-02-05 14.41
2024-02-02 14.44
2024-02-01 14.52
2024-01-31 14.34
2024-01-30 14.76
2024-01-29 14.79
2024-01-26 14.56
2024-01-25 14.16
2024-01-24 14.17
2024-01-23 14.22
2024-01-22 14.32
2024-01-19 14.11
2024-01-18 13.78
2024-01-17 13.64
2024-01-16 13.80
2024-01-12 14.08
2024-01-11 14.19
2024-01-10 14.17
2024-01-09 14.28
2024-01-08 14.92
2024-01-05 14.76
2024-01-04 14.73
2024-01-03 14.76
2024-01-02 15.32
2023-12-29 15.44
2023-12-28 15.57
2023-12-27 15.57
2023-12-26 15.54
2023-12-22 15.43
2023-12-21 15.40
2023-12-20 15.18
2023-12-19 15.40
2023-12-18 14.99